![Luigi Grasso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Luigi Grasso was the founder of two companies, Morphotek, Inc. (founded in 2000) and Navrogen, Inc. (founded in 2017), where he held the title of Chief Scientific Officer and Director, Chief Scientific Officer & Senior VP respectively.
He worked at Morphotek, Inc. from 2011 to 2018.
Dr. Grasso holds a doctorate degree from the University of Catania.
Actieve functies van Luigi Grasso
| Bedrijven | Functie | Begin |
|---|---|---|
Navrogen, Inc.
 Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Oprichter | 01-01-2017 |
Eerdere bekende functies van Luigi Grasso
| Bedrijven | Functie | Einde |
|---|---|---|
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Oprichter | 01-04-2018 |
Opleiding van Luigi Grasso
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Morphotek, Inc.
Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
University of Catania
 University of Catania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
